SCHEMBL20913066

SCHEMBL20913066

Cn1c(C(=O)N2CCCC(C(=O)O)C2)cc2c(Nc3ccc(OC(F)(F)F)cc3)ncnc21

nearest known ligand 0.49

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 16/20 0.49
BCR P11274 16/20 0.49
GCGR P47871 1/20 0.44
MAPK1 P28482 1/20 0.43
EPHX2 P34913 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3399457 0.94 ABL1 (0.49) ABL1BCREPHX2
SCHEMBL3396834 0.90 HSD17B10 (0.51) ABL1BCRMAPK1
SCHEMBL3402608 0.88 EPHX2 (0.54) ABL1BCREPHX2
SCHEMBL3396839 0.85 ABL1 (0.55) ABL1BCR
SCHEMBL3403375 0.84 ABL1 (0.56) ABL1BCR
SCHEMBL13821120 0.84 ABL1 (0.56) ABL1BCR
SCHEMBL13821497 0.81 ABL1 (0.49) ABL1BCR
SCHEMBL3399887 0.81 ABL1 (0.49) ABL1BCR
SCHEMBL16331109 0.81 ABL1 (0.62) ABL1BCR
SCHEMBL16363315 0.81 HSD17B10 (0.42) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3150593-B1 SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE DANA FARBER CANCER INST INC (US) 2019-04-24 EP claimed